The Use of Residual De-identified Specimens and/or Samples From Patients for Clinical Research
The Use of Residual De-identified Specimens and/or Samples From Patients for Clinical Research
Recruiting · NCT06222164 · Registry updated 2025-05-04Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| The Use of Residual De-identified Specimens and/or Samples From Patients for Clinical Research | Hemic and Lymphatic Diseases, hematologic disorder | Recruiting | Not stated | 2025-05-04 | NCT06222164 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Invivoscribe, Inc. | 2 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| LabPMM | San Diego | United States | 1 |